Tau2024 | March 25-26, 2024 | Washington, D.C., and online

About the Conference

Leading tau experts convened for the Tau2024 Global Conference to collaborate and discuss key issues impacting the tau research community. This in-person and online conference provided a forum for members of academia, industry, philanthropy and government to:

  • Discuss tau-based biology, biomarkers, therapeutics and phenotypes.
  • Attract talent and funding to the study of tauopathies, particularly among early career researchers.
  • Increase interdisciplinary alignment and collaboration around challenges in tau research.

Topics included biomarkers, clinical manifestations, drug development, risk and environmental factors, genetics, molecular and cell biology, neuropathology, and more.

View the 2024 conference program.

Research Themes

All were invited to submit abstracts on the latest findings and ideas in tau research. Applicable themes include:

  • Biomarkers — Neuroimaging.
  • Biomarkers — Non-Neuroimaging.
  • Clinical Manifestations.
  • Drug Development — Human.
  • Drug Development — Non-Human.
  • Risk and Environmental Factors.
  • Genetics.
  • Molecular and Cell Biology.
  • Neuropathology.

Scientific Program Committee

  • Bess Frost, chair
  • James Rowe, chair
  • Luc Buée
  • Claire Clelland
  • Ratnavalli Ellajosyula
  • Makoto Higuchi
  • Günter Höglinger
  • Mahmoud Maina
  • Miranda Orr
  • Jon Rohrer
  • Susanne Wegmann
  • Kristin Wildsmith
  • Henrik Zetterberg


Companies interested in sponsoring future conferences can contact Tommy Morris, Senior Director of Corporate Initiatives, at tomorris@alz.org.

Appropriate Conduct Policy

Tau2024 aims to provide a safe, equitable, and accessible experience for all conference participants.

Read the full Statement of Appropriate Conduct (PDF).


General questions: TauGlobal@alz.org
Media questions: media@alz.org

Conference Details

Date: March 25-26, 2024
Location: Washington, D.C., and online

Collaborate Year-Round with a Global Research Community

Network and collaborate year-round with ISTAART, a global community of scientists, clinicians and dementia professionals who are working to advance Alzheimer’s and dementia research and treatment.


Join the Conversation


We use cookies to improve your experience on this website. Learn about options for managing your personal data in our Privacy Policy.